Showing results (11-20 of 213) with videos related to
Sort By:
Pageof 22
Pharmacopsychiatry|May 1, 1993
The pharmacotherapy of obsessive-compulsive disorderC J McDougle, W K Goodman, L H PriceJournal of Autism and Developmental Disorders|December 1, 1990
Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case reportC J McDougle, L H Price, W K GoodmanThe Journal of Clinical Psychiatry|April 1, 1992
Pharmacotherapy of obsessive compulsive disorderW K Goodman, C J McDougle, L H PriceThe American Journal of Psychiatry|April 1, 1993
Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorderC J McDougle, W K Goodman, J F Leckman, et al.Biological Psychiatry|August 1, 1995
m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbationW K Goodman, C J McDougle, L H Price, et al.The Psychiatric Clinics of North America|December 1, 1993
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesisC J McDougle, W K Goodman, J F Leckman, et al.Psychoneuroendocrinology|January 1, 1994
The role of central oxytocin in obsessive compulsive disorder and related normal behaviorJ F Leckman, W K Goodman, W G North, et al.Biological Psychiatry|May 1, 1997
Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjectsL C Barr, G R Heninger, W Goodman, et al.The American Journal of Psychiatry|August 1, 1987
Treatment of severe obsessive-compulsive disorder with fluvoxamineL H Price, W K Goodman, D S Charney, et al.The American Journal of Psychiatry|July 1, 1986
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three casesW K Goodman, D S Charney, L H Price, et al.Pageof 22